Australia's largest stock trading and investment forum Australia's #1 stock forum

SPL

Click for more information

1.08%

9.2¢ starpharma holdings limited

Ann: Viraleze shows antiviral efficacy in COVID-19 patients, page-19

First 19 Last

Share
Profile

Follow
WBA

2,384 Posts.

422

29/01/24

10:46

Post #: 72106045
Share

Originally posted by Jace1984: ↑

It did achieve the primary endpoint:

"Viraleze™ achieved a statistically significantly lower level of SARS-CoV-2 viral load3 in the nose over the 7-day treatment period, which was the primary endpoint of the study, than a placebo nasal spray in the cohort of participants aged 45 years and over (N=118, p=0.017)."

Also worth noting is this comment:

"Of note, treatment compliance and vaccination rates were lowest in participants aged under 40."

It has clinical benefit, especially for older cohorts (aged care and hospitals spring to mind, as well as travel) and importantly it has little or no side effects, so it has a good risk/reward profile.

The target market would be over 40s anyway IMO. My kids hate taking the stuff, and they are adults now, so no surprise they had trouble with compliance in younger participants!

They just need to get the approvals, deals and dollars through the door.

Expand

Air line and cruise industries scream out here.....along with aged care, hospitals, other medical sites...

SPL Price at posting: 15.0¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

What's causing the cost-of-living crisis, and how to navigate it

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

There are more pages in this discussion • 56 more messages in this thread...

First 19 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.2¢		Change -0.001(1.08%)		Mkt cap ! $38.39M

Open	High	Low	Value	Volume
9.2¢	9.3¢	9.1¢	$210.6K	2.290M

Buyers (Bids)

No.	Vol.	Price($)
1	467139	9.2¢

Sellers (Offers)

Price($)	Vol.	No.
9.4¢	152000	2

View Market Depth

No.	Vol.	Price($)
1	467139	0.092
1	22730	0.091
6	98353	0.090
2	80283	0.089
2	45464	0.088

Price($)	Vol.	No.
0.094	152000	2
0.095	9947	1
0.096	104177	1
0.098	159206	3
0.099	50000	1

Last trade - 16.10pm 18/10/2024 (20 minute delay)

SPL (ASX) Chart